🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to explore the efficacy of high intensity transcranial alte...
Status
Not Yet Recruiting
Location
Shanghai Mental Health Center
Start Date
2025-12-01
Trial ID
NCT07227545
Treatments Being Tested
This study focuses on individuals with primary hypertension, with the main ...
Status
Not Yet Recruiting
Location
Xuanwu Hospital, Capital Medical University
Start Date
2026-05-01
Trial ID
NCT07566650
This study aims to evaluate the efficacy of transcranial alternating curren...
Status
Enrolling By Invitation
Location
Shanghai Pudong New Area Mental Health Center
Start Date
2025-06-11
Trial ID
NCT07074704
Treatments Being Tested
This study is a double-blind, randomized, controlled intervention study aim...
Status
Unknown
Location
Zhejiang Tongde Hospital
Start Date
2023-11-14
Trial ID
NCT06231732
The investigators assume that High-intensity transcranial Alternating Curre...
Status
Recruiting
Location
Shanghai Mental Health Center
Start Date
2026-06-01
Trial ID
NCT07228182
Treatments Being Tested
In 2021, nearly 296 million people worldwide used psychoactive substances, ...
Status
Active Not Recruiting
Location
Beijing Tiantanghe Addiction Rehab Center
Start Date
2021-11-21
Trial ID
NCT06288997
The goal of this clinical trial is to investigate whether Hi-tACS is effect...
Status
Recruiting
Location
Shanghai Mental Health Center
Start Date
2024-06-27
Trial ID
NCT06888726
This study is a double-blind, randomized, controlled intervention study aim...
Status
Recruiting
Location
Sir Run Run Shaw Hospital
Start Date
2024-04-01
Trial ID
NCT06470516
This study aims to comprehensively evaluate the therapeutic effects of high...
Status
Recruiting
Location
Department of Neurology, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China
Start Date
2025-09-01
Trial ID
NCT07558616
Treatments Being Tested